Quarter Financials
Myriad Genetics, Inc. (MYGN)
$18.015
+0.04 (+0.19%)
Income Statement
Balance Sheet
Cash Flow
|
Year
|
2023 Q2
|
2023 Q1
|
2022 Q4
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
|---|
| Net Income | -116 | -55 | -42 | -35 | -14 | -21 | -8 | 25 |
|---|
| Dividend Paid | - | - | - | - | - | - | - | - |
|---|
| Retained Earnings | -537 | -421 | -366 | -324 | -289 | -275 | -254 | -247 |
|---|
|
Year
|
2023 Q2
|
2023 Q1
|
2022 Q4
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
|---|
| Capital Expenditure | -19 | -24 | -15 | -18 | -7 | -6 | -3 | -3 |
|---|
| Net PPE | 219 | 203 | 187 | 178 | 136 | 117 | 125 | 127 |
|---|
|
Year
|
2023 Q2
|
2023 Q1
|
2022 Q4
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
|---|
| New Purchases | -64 | -47 | -52 | -33 | -13 | -4 | - | - |
|---|
| Intangible and Goodwill | 240 | 239 | 239 | 238 | 237 | 287 | 287 | 287 |
|---|